Jhanelle Gray, MD
Jhanelle Gray, MD
Faculty Rank:
Assistant Member
Titles:
Department/Program Affiliations:
-
Thoracic Oncology
-
Experimental Therapeutics
-
Breast
Primary Address:
H. Lee Moffitt Cancer Center &
Research Institute
12902 Magnolia Drive
Tampa,
FL
33612
Consultation/Referral Phone:
(813) 745-3050
USF Affiliations/College Department:
-
Medicine / Oncologic Sciences
University Academic Rank:
Assistant Professor
For corrections, please e-mail a request
Printer friendly version
Printer friendly version (including publications)
Jhanelle Gray, MD
Education & Training:
-
MD, Wiell Medical College of Cornell University, New York, NY, 2001 - Medical Doctor
-
Residency, The New York Presbyterian Hospital, New York, NY, 2004
-
Fellowship, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 2007 - Hematology/Oncology
General Board Certification / SubSpecialty:
-
Internal Medicine
-
Internal Medicine / Medical Oncology
-
Internal Medicine / Hematology
For corrections, please e-mail a request
Printer friendly version
Printer friendly version (including publications)
Jhanelle Gray, MD
Research Interests:
My research interests include the chemoprevention of lung cancer and the targeting of treatment based on genetics in breast cancer patients.
Clinical Interests:
My clinical interests focus upon thoracic and breast oncology.
For corrections, please e-mail a request
Printer friendly version
Printer friendly version (including publications)
Jhanelle Gray, MD
Below is a list of active grants where the faculty member is the Principal Investigator. Grants are sorted by sponsor and then sorted by start date, with the more recent grant shown first.
Phase I Dose Escalation Study of LY2090314 in Pts with Adv or Metastatic CA with Pemetrexed/Carboplatin
|
|
Sponsor:
|
Eli Lilly & Company
|
|
Project Dates:
|
September 6, 2007 to
September 5, 2010
|
|
Annual Direct Cost:
|
$13,322
|
|
Annual Total Cost:
|
$17,318
|
|
Project Total:
|
$214,347
|
IPI-504 in Relapsed and/or Refractory Stage IIIb or Stage IV NSCLC Patients
|
|
Sponsor:
|
Infinity Pharmaceutical
|
|
Project Dates:
|
December 4, 2008 to
December 3, 2010
|
|
Earned to Date:
|
$111,307
|
SPORE in Lung Cancer/Supplement to Project 04 (Bepler)
3 P50 CA119997-02S3
|
|
Sponsor:
|
Nat Institutes of Health / NCI
|
|
Project Dates:
|
September 1, 2009 to
August 31, 2011
|
|
Annual Direct Cost:
|
$94,910
|
|
Annual Total Cost:
|
$158,500
|
|
Project Total:
|
$317,148
|